A ‘revolutionary’ new painless IUD comes to marketThe Yanae intra-uterine device, developed in France and distributed by the young Canadian pharmaceutical company 49Care, incorporates a flexible inserter for pain-free insertion. Non-hormonal drugs show promise for moderate to severe menopause symptomsTreatments that tackle vasomotor symptoms like hot flushes head-on, without hormones, are increasingly coming onto the market. The immigrants When present, they are not noticed, and when absent, they are not missed, says Dr. Jabir Jassam, reflecting on feelings of blurred identity. B.C. breaks vaccination records, with 82,000 COVID-19 and flu shots in one day Record numbers of people in British Columbia have received updated vaccinations against COVID-19 and flu, as the province ramps up its immunization campaign for respiratory illness season. Taking a vasodilator in film form allows treatment erectile dysfunction to be more discreet Viagra in orodispersible film form is now available in Canada. Have your say: CPSO seeking input on its updated ‘consent to treatment’ policy Expanded guidance sets out expectations for the professional conduct of Ontario physicians around issues of patient consent. RSV shot for infants available in Ont., N.WT. and coming to Quebec, Yukon, Nunavut The new shot called Nirsevimab—also known by the brand name Beyfortus—gives babies antibodies that provide passive immunity to RSV. COVID‐19 is not the flu: How differences across viruses and vaccines impact patient care How different configurations of pharmacare could affect pharmacy bottom lines The choice between a single-payer plan and a mixed-payer one could have a profound impact on pharmacies’ workload and revenues. Part 2: A fine balance The science of ending a doctor-patient relationship (more advice to early career colleagues) from Dr. Eric Cadesky. First Previous 44 45 46 47 48 Next Last
